Boston Scientific · 14 hours ago
Laboratory Tech III
Boston Scientific is a leader in medical science committed to solving health industry challenges. The Laboratory Tech III role involves providing technical support for in vitro biomedical research studies, contributing to developing and optimizing new models, and maintaining detailed records.
Health CareMedicalMedical Device
Responsibilities
Contributing to developing and/or optimizing new in vitro (cell, blood and tissue) models
Following experimental protocols and executing test methods both independently and with guidance from senior team members
Maintaining detailed and accurate records
Assisting with preparation of data for reporting and presentation
Assisting with equipment maintenance, cleaning and inventory management
Qualification
Required
3 Years with Associate with Biology degree/diploma, or an equivalent combination of education/work experience
Preferred
Familiarity with BSL‑2 laboratory operations and handling of blood-derived materials
Hands-on experience in cell biology techniques, e.g. hemocompatibility testing (highly desirable), microscopy, immunostaining, flow cytometry, and/or cell culture
Ability to quickly learn new techniques and adapt in a changing environment
Excellent time management skills and ability to multi-task
Excellent written and communication skills
Ability to work effectively in a team setting and on an individual basis
Results and detail-oriented
Benefits
Compensation may also include variable compensation from time to time (e.g., any overtime and shift differential) and annual bonus target (subject to plan eligibility and other requirements).
Compensation may also include variable compensation, i.e., annual bonus target and long-term incentives (subject to plan eligibility and other requirements).
Company
Boston Scientific
Boston Scientific is a medical technology company that designs and develops medical devices to diagnose and treat a wide range of condition.
Funding
Current Stage
Public CompanyTotal Funding
$10.02B2025-02-21Post Ipo Debt· $1.58B
2024-02-22Post Ipo Debt· $2.17B
2022-03-04Post Ipo Debt· $3.28B
Recent News
BioWorld Financial Watch
2026-01-16
2026-01-16
2026-01-16
Company data provided by crunchbase